These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 686309)

  • 1. Attempted reduction of the cardiostimulatory effects of ketamine by labetalol.
    Dundee JW; Lilburn JK; Moore J
    Anaesthesia; 1978 Jun; 33(6):506-11. PubMed ID: 686309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempts to attenuate the cardiostimulatory effects of ketamine.
    Lilburn JK; Moore J; Dundee JW
    Anaesthesia; 1978 Jun; 33(6):499-505. PubMed ID: 686308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive effects of labetalol in three types of hypertensive models of rats (author's transl)].
    Nakagawa Y; Takeda K; Sakurai H; Mitomi A; Imai S
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):435-45. PubMed ID: 7286847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine and metabolic effects of labetalol in man.
    Barbieri C; Ferrari C; Caldara R; Crossignani RM; Bertazzoni A
    J Cardiovasc Pharmacol; 1981; 3(5):986-91. PubMed ID: 6168866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM; Hilditch A; Levy GP
    Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of labetalol and propranolol on responses to adrenaline infusion in healthy volunteers.
    Doshi BS; Kulkarni RD; Dattani KK; Anand MP
    Int J Clin Pharmacol Res; 1984; 4(1):29-33. PubMed ID: 6469431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical inotropic effects of clonidine and labetalol in the conscious rabbit.
    McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1981; 3(4):818-27. PubMed ID: 6167811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological basis for antihypertensive effects of intravenous labetalol.
    Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
    Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow.
    Lunell NO; Nylund L; Lewander R; Sarby B
    Br J Obstet Gynaecol; 1982 Aug; 89(8):640-4. PubMed ID: 7104255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
    Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
    Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive and vascular effects of labetalol in the normotensive rat and dog.
    Hashimoto K; Hashimoto T; Iizuka H; Tsukada T; Matsuda H; Imai S
    Jpn Heart J; 1978 Sep; 19(5):762-74. PubMed ID: 32409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
    Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.
    Richards DA; Woodings EP; Maconochie JG
    Br J Clin Pharmacol; 1977 Feb; 4(1):15-21. PubMed ID: 843418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the haemodynamic effects of labetalol in man.
    Cohn JN; Mehta J; Francis GS
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.